1-1 of 1
Yanmei Xu, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

GSK1120212, a MEK1/MEK2 Inhibitor, Demonstrates Acceptable Tolerability and Preliminary Activity In a Dose Rising Trial In Subjects with AML and Other Hematologic Malignancies

Gautam Borthakur, MD, James M. Foran, MD, FRCPC, Tapan Kadia, MD, Elias Jabbour, MD, Paul Wissel, MD, Donna Cox, PhD, Yanmei Xu, PhD, John Bauman, PhD, Melanie Baccus, RN, Jeanne Connor, RN, OCN, Jorge E. Cortes, MD, Hagop Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 3281.
https://doi.org/10.1182/blood.V116.21.3281.3281
Published: 2010